Lymphedema
Conditions
Keywords
Quality of Life (QoL), 17-377
Brief summary
This study is being done to see the long-term results for patients who choose to have surgery for lymphedema (with the vascularized lymph node transfer), compared to patients who choose not to have surgery.
Interventions
Upper Limb Lymphedema (ULL-27), Lymphedema Life Impact Scale, version 2 (LLISv2), LYMQOL-Leg.
Sponsors
Study design
Eligibility
Inclusion criteria
* Patients aged 18-80 years * Primary and secondary lymphedema of the upper or lower extremity * International Society of Lymphology (ISL) Stage 1, 2, or 3 lymphedema * Proficiency in English language
Exclusion criteria
* Patients with clotting disorders, venous insufficiency, end-stage lymphedema unless they are on the non-surgical arm. * Additionally, if the patient refuses to complete questionnaires, the patient will be excluded from the study and replaced at the discretion of the principal or co-principal investigator.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Quality of Life | up to 40 months | Questionnaire to assess quality of life changes |
Countries
United States